* Mesa Laboratories Inc MLAB.OQ reported quarterly
adjusted
earnings of 24 cents per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of 31 cents per share.
* Revenue rose 63.9% to $58.75 million from a year ago;
analysts
expected $53.30 million.
* The mean earnings estimate of analysts had fallen by
about 126.8% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Mesa Laboratories Inc shares had fallen by 9.1% this
quarter and
lost 61.0% so far this year.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $180.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
3 at 01:04 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.31 0.24 Beat
Jun. 30 2022 1.00 -0.27 Missed
Mar. 31 2022 0.48 -0.34 Missed
Dec. 31 2021 0.42 0.61 Beat